CClinicalTrials.gg
CompletedNCT02130960Updated Feb 2, 2022

Resting Metabolic Rate Reliability

An observational study in Resting Metabolic Rate Reliability, sponsored by USDA Grand Forks Human Nutrition Research Center. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-02-02.

Sponsored by USDA Grand Forks Human Nutrition Research Center · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This research is being conducted to study the reliability of a method used to measure resting metabolic rate, or how much energy a person expends while at rest.

02

Conditions studied

  • Resting Metabolic Rate Reliability

Keywords

  • RMR
  • Reliability
  • Obese
  • Energy Expenditure
  • Resting Energy Expenditure
  • Resting Metabolic Rate
03

In context

Lead sponsor

USDA Grand Forks Human Nutrition Research Center is the lead sponsor of 58 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants will include up to 15 men and 15 women age 18 -65 years old with a BMI of 19 - 40 kg/m2.

Inclusion criteria

  • Age 18 - 65 years old
  • BMI of 19 - 40 kg/m2
  • Women must not be pregnant or planning to become pregnant

Exclusion criteria

Exclusion Criteria:

  • Age less than 18 or greater than 65
  • BMI less than 19 or greater than 40
  • Tobacco use
  • Taking medications that affect metabolic rate (unless weight stable for past 3 months)
  • Any disease that affects the metabolic rate
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Resting Metabolic Rate by Indirect Calorimetry

    The within-subject coefficient of variation for resting metabolic rate (RMR) will be less than 10%. Testing will occur on non-consecutive days, with a compliance and menstrual cycle questionnaire prior to testing.

    Time frame: At least 3 days

Secondary outcomes

  1. Respiratory Quotient Variation

    The within-subject coefficient of variation for respiratory quotient (RQ) will be less than 10%. Testing will occur on non-consecutive days, with a compliance and menstrual cycle questionnaire prior to testing.

    Time frame: At least 3 days

  2. Sense Wear Mini Armband verses Indirect Calorimetry

    The limits of agreement of Sense Wear Mini Armband (SWA)-estimated resting energy expenditure (REE) with indirect calorimetry measures of REE will be large (+ 500 kcal). Testing will occur on non-consecutive days, with a compliance and menstrual cycle questionnaire prior to testing.

    Time frame: At least 3 days

07

Study locations

1 site
  • USDA Grand Forks Human Nutrition Research Center
    Grand Forks, North Dakota 58203, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02130960
Lead sponsor
USDA Grand Forks Human Nutrition Research Center
Responsible party
Sponsor
First posted
May 6, 2014
Start date
Apr 2014
Primary completion
Sep 2014
Completion
Dec 2015
Last update
Feb 2, 2022

Study contacts

James Roemmich, PhD
principal investigator · USDA Grand Forks Human Nutrition Research Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion